HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Compound

2,2',3,4,4'-Pentachlorobiphenyl

HCID 47651
New noteNew reactionRequest quotes
Print preview
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
65510-45-4
Standard SMILES
Clc1ccc(-c2ccc(Cl)c(Cl)c2Cl)c(Cl)c1
InChIKey
LACXVZHAJMVESG-UHFFFAOYSA-N
Molecular formula
C12H5Cl5
Average molar mass
326.4 g/mol
Monoisotopic mass
323.883389

Overview

2,2',3,4,4'-Pentachlorobiphenyl is one of 209 polychlorinated biphenyls (PCBs). PCBs are a group of synthetic organic compounds with 1-10 chlorine atoms attached to biphenyl. They were manufactured as commercial mixtures but banned in the 1970's because they were found to bioaccumulate and cause harmful health effects. However, PCBs do not break down readily and are still found in the environment. (L4)

Names & identifiers

Preferred name
2,2',3,4,4'-Pentachlorobiphenyl
IUPAC
1,2,3-trichloro-4-(2,4-dichlorophenyl)benzene
English name
2,2',3,4,4'-Pentachlorobiphenyl
Molecular formula
C12H5Cl5
Molecular weight
326.43

Names & synonyms

2,2',3,4,4'-PENTACHLOROBIPHENYL2,2',3,4,4'-Pentachloro-1,1'-biphenylUNII-978Z792J4S978Z792J4SDTXSID90735991,1'-Biphenyl, 2,2',3,4,4'-pentachloro-RefChem:53491DTXCID804462065510-45-4PCB 851,2,3-trichloro-4-(2,4-dichlorophenyl)benzenePCB No. 85
Show more names
BZ# 85BZ NO 85PCB NO 85Farnesane Impurity 112,2',3,4,4'-PENTACB (PCB-85)2,2',3,4,4'-Pentachlorobiphenyl 99% (BZ# 85)
1,1'-Biphenyl, 2,2',3,4,4'-pentachloroSCHEMBL4454517LACXVZHAJMVESG-UHFFFAOYSA-NNS00077127Q272719842,2',3,4,4'-Pentachlorobiphenyl, BZ# 85, vial of 100 mg2,2',3,4,4'-Pentachlorobiphenyl, 99%, vial of 10 mg, BZ# 85, analytical standard

Database identifiers

CAS
65510-45-4
PubChem CID
47651
DTXSID
DTXSID9073599

Properties

Computed structural properties

XLogP
6.6
Topological polar surface area
0 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
0
Rotatable bonds
1
Heavy atoms
17
Formal charge
0
Complexity
259

Experimental & physicochemical properties

LogP6.18
Endocrine DisruptorsPotential endocrine disrupting compound
Collision Cross Section159.9 Ų [M]+ [CCS Type: TIMS, Method: calibration with PAHs]

Physicochemical properties

Melting point
95.86 °C · 95.86°C (estimate)
Boiling point
412.3 °C · 412.3°C (rough estimate)
Density
1.522 · 1.5220 (rough estimate)
refractive index
1.62 · 1.6200 (rough estimate)
storage temp.
room temp
Water Solubility
21.91 ug/L · 21.91ug/L(20 ºC)
Henry's Law Constant
2.3 · 2.3×10-2 mol/(m3Pa) at 25℃, Bamford et al. (2002)
FDA UNII
978 Z792J4S · 978Z792J4S
EPA Substance Registry System
2 · 2,2',3,4,4'-Pentachlorobiphenyl (65510-45-4)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 5 items

This chemical does not meet GHS hazard criteria for 7.3% (3 of 41) of reports.

Warning

H373 (92.7%): May causes damage to organs through prolonged or repeated exposure [Warning Specific target organ toxicity, repeated exposure]

P260, P273, P319, P391, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 41 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazard Classes and CategoriesSTOT RE 2 (92.7%)

Safety & protection

Minimum Risk LevelIntermediate Oral: 0.03 ug/kg/day (L134)

Toxicology

Treatment · 1 item

There are no specific treatments for PCB poisoning, since it is not usually recognized until after substantial chronic exposure. Only preventing further exposure and treating the observed symptoms can be done. Acute inhalation can be treated by administering oxygen. (L4)

Health Effects · 1 item

The most common health effects of PCBs are skin conditions such as chloracne and rashes. Chronic PCB exposure has also been shown to cause liver, stomach and kidney, damage, jaundice, edema, anemia, changes in the immune system, behavioral alterations, and impaired reproduction. (L4)

Exposure Routes

Chemistry & industry

Pharmacology

Metabolism/Metabolites · 1 item

PCBs are absorbed via inhalation, oral, and dermal routes of exposure. They are trasported in the blood, often bound to albumin. Due to their lipophilic nature they tend to accumulate in lipid-rich tissues, such as the liver, adipose, and skin. Metabolism of PCBs is very slow and varies based on the degree and position of chlorination. PCBs are metabolized by the microsomal monooxygenase system catalyzed by cytochrome P-450 enzymes to polar metabolites that can undergo conjugation with glutathione and glucuronic acid. The major metabolites are hydroxylated products which are excreted in the bile and faeces. The slow metabolism of PCBs means they tend to accumulate in body tissues. (L4, T6)

Uses & manufacturing

Uses · 1 item

PCBs were used as coolants and lubricants in transformers, capacitors, and other electrical devices (such as fluorescent lights and refridgerators) produced before 1977. PCBs may contaminate the air and water near hazardous waste sites. In addition, PCBs bioaccumulate in the environment and may be found in fish, meat, and dairy products. (L4)

Applications

Uses2,2'',3,4,4''-Pentachlorobiphenyl is a polychlorinated biphenyl (PCB) congeners.

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
More actions
New noteNew reactionRequest quotes
UNII
978Z792J4S
EC Number
690-285-3
Nikkaji
J164.839J
Symbol(GHS)
8 · GHS08,GHS09
Signal word
Warning
Hazard statements
373 · H373-H410
Precautionary statements
273 · P273-P391-P501
Hazard Codes
N
Risk Statements
33 · 33-50/53
Safety Statements
60 · 60-61
RIDADR
3432 · UN 3432 9 / PGII
Oral (L4) ; inhalation (L4) ; dermal (L4)
Toxicity Summary · 1 item

The mechanism of action varies with the specific PCB. Dioxin-like PCBs bind to the aryl hydrocarbon receptor, which disrupts cell function by altering the transcription of genes, mainly be inducing the expression of hepatic Phase I and Phase II enzymes, especially of the cytochrome P450 family. Most of the toxic effects of PCBs are believed to be results of Ah receptor binding. Other PBCs are believed to interfere with calcium channels and/or change brain dopamine levels. PCBs can also cause endocrine disurption by altering the production of thyroid hormones and binding to estrogen receptors, which can stimulate the growth of certain cancer cells and produce other estrogenic effects, such as reproductive dysfunction. They will bioaccumulate by binding to receptor proteins such as uteroglobin. (A3, A4, A30, A66)

Signs and SymptomsChronic PCB exposure results in symptoms such as abdominal pain, nausea, vomiting, diarrhea, headache, dizziness, depression, nervousness, dermal and ocular lesions, fatigue, irregular menstrual cycles and a lowered immune response. (A3)
Carcinogen Classification1, carcinogenic to humans. (L135)
Toxicity DataLD50: 1010 mg/kg (Oral, Rat) (T14) LD50: 880 mg/kg (Intraperitoneal, Mouse) (T14)

Safety data

ridadr
UN 3432 9 / PGII
risk_code
33-50/53
Signal word
Warning
Symbol(GHS)
GHS08,GHS09
hazard_code
N
safety_code
60-61
Hazard statements
H373-H410
Precautionary statements
P273-P391-P501